セフィキシム

セフィキシム 化学構造式
79350-37-1
CAS番号.
79350-37-1
化学名:
セフィキシム
别名:
(6R,6β)-7α-[[(2-アミノ-4-チアゾリル)[(Z)-(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸;(6R,7R)-7-[[(2-アミノ-4-チアゾリル)[(Z)-(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸;セフィーナ;セフィキシム;セキシム;セフスパン;抗生物質FK-027;セフパ;(6R)-7α-[[(2-アミノ-4-チアゾリル)[(Z)-(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸;セフィラート;(6R,7R)-7-[[(Z)-(2-アミノ-4-チアゾリル)[(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸;セキスパノン;セフィキシム (JAN)
英語名:
Cefixime
英語别名:
CEFIXIME TRIHYDRATE;Cefixim;Cefspan;Suprax;Cefixime USP;CEFIXIME MICRONIZED;CFIX;fk027;Oroken;Saprax
CBNumber:
CB4210362
化学式:
C16H15N5O7S2
分子量:
453.45
MOL File:
79350-37-1.mol

セフィキシム 物理性質

融点 :
218-225°C
比重(密度) :
1.85±0.1 g/cm3(Predicted)
貯蔵温度 :
Keep in dark place,Inert atmosphere,2-8°C
溶解性:
水にわずかに溶け、メタノールに溶け、無水エタノールに溶けにくく、酢酸エチルにほとんど溶けない。
酸解離定数(Pka):
pKa 2.10 (Uncertain)
外見 :
個体
色:
オフホワイトからペールイエロー
水溶解度 :
55.11mg/L
BCS Class:
4
安定性::
吸湿性
CAS データベース:
79350-37-1(CAS DataBase Reference)
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
主な危険性  Xn
Rフレーズ  42/43
Sフレーズ  22-36/37-45
WGK Germany  3
10-23
HSコード  38210000
毒性 LD50 oral in rat: > 10gm/kg
絵表示(GHS) GHS hazard pictograms
注意喚起語 警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H302 飲み込むと有害 急性毒性、経口 4 警告 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 皮膚刺激 皮膚腐食性/刺激性 2 警告 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 強い眼刺激 眼に対する重篤な損傷性/眼刺激 性 2A 警告 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 呼吸器への刺激のおそれ 特定標的臓器毒性、単回暴露; 気道刺激性 3 警告 GHS hazard pictograms
注意書き
P261 粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。
P305+P351+P338 眼に入った場合:水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

セフィキシム 価格 もっと(8)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01TRCC242800 セフィキシム
Cefixime
79350-37-1 1mg ¥17300 2023-06-01 購入
富士フイルム和光純薬株式会社(wako) W01TRCC242800 セフィキシム
Cefixime
79350-37-1 5mg ¥29700 2023-06-01 購入
富士フイルム和光純薬株式会社(wako) 45948-1A
Cefixime
79350-37-1 1g ¥7920 2024-07-01 購入
Sigma-Aldrich Japan CDS021590
Cefixime
79350-37-1 100MG ¥24400 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01TRCC242800 セフィキシム
Cefixime
79350-37-1 10mg ¥44100 2024-03-01 購入

セフィキシム 化学特性,用途語,生産方法

効能

抗生物質, 細胞壁合成阻害薬

説明

Cefixime is the first orally active third-generation cephalosponn with a true broad spectrum of activity. It is reportedly more effective against Gram-negative bacteria than conventional oral cephems such as cephalexin and cefaclor.

化学的特性

Cefixime is an oral third generation cephalosporin antibiotic. It was sold under the trade name Suprax in the United States until 2003. The oral suspension form of “Suprax” was re-launched. Cefixime is prescribed for bacterial infections of the chest, ears, urinary tract, and throat (tonsilitis and pharyngitis), and for uncomplicated gonorrhea, upper and lower respiratory tract infections, acute otitis media, and gonococcal urethritis.

定義

ChEBI: A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

抗菌性

It is active against N. gonorrhoeae, M. catarrhalis, H. influenzae and a wide range of enterobacteria, including most strains of Citrobacter, Enterobacter and Serratia spp. Its antistaphylococcal activity is poor. It is not active against Acinetobacter spp., Ps. aeruginosa or B. fragilis. It is resistant to hydrolysis by common β-lactamases.

健康ハザード

Exposures to cefi xime may cause side effects that include, but are not limited to, stomach and abdominal pain, diarrhea, vomiting, mild skin rash, headache, fever, urticaria, pruritis, eosinophilia, leucopenia, anaphylaxis, superinfection, hemolytic anemia, dyspepsia, and fl atulence. Also, cefi xime may cause transient elevation of SGOT, SGPT, alkaline phosphatase, BUN, and creatinine. Reports have indicated that cefi xime is mainly excreted unchanged in the bile and urine

薬物動態学

Oral absorption: c. 50%
Cmax 400 mg oral: 4–5.5 mg/L after 4 h
Plasma half-life: 3-ndash;4 h
Volume of distribution: 0.1 L/kg
Plasma protein binding: 60-ndash;70%
Absorption and distribution
Oral absorption is slow and incomplete, but is unaffected by aluminum magnesium hydroxide. Penetration into cantharides blister fluid was very slow but exceeded the plasma level. CSF concentrations are poor even in the presence of meningeal inflammation, reaching an average of around 0.22 mg/L in children with meningitis.
Metabolism and excretion
It is not metabolized and is excreted unchanged in urine (mainly by glomerular filtration) and in bile, in which concentrations exceeding 100 mg/L have been found. Less than 20% of an oral dose is recovered from the urine over 24 h, falling to less than 5% in patients with severe renal impairment, with a corresponding increase in plasma concentration. It is not removed by peritoneal or hemodialysis.

臨床応用

Cefixime has been used successfully in uncomplicated cystitis, upper and lower respiratory tract infections and various other infections. Its failure to provide adequate cover for staphylococci should be noted.

副作用

It is well tolerated, but diarrhea is fairly common and pseudomembranous colitis has been reported. Other side effects common to cephalosporins are occasionally seen.

予防処置

Users of cefi xime should be careful in health conditions such as neonates, pregnancy, lactation, and renal failure. Users should follow suitable and appropriate health care measures to control superinfection (if it happens during therapy). It is contraindicated in patients with a known allergy to penicillin or any other ingredients of Taximax. Taxim-O is contraindicated in patients with a known allergy to the cephalosporin group of antibiotics.

セフィキシム 上流と下流の製品情報

原材料

準備製品


セフィキシム 生産企業

Global( 552)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Hebei Weibang Biotechnology Co., Ltd
+8615531157085
abby@weibangbio.com China 8812 58
Sinoway Industrial co., ltd.
0592-5800732; +8613806035118
xie@china-sinoway.com China 988 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971
deasea125996@gmail.com China 2472 58
Guangzhou Tengyue Chemical Co., Ltd.
+86-86-18148706580 +8618826483838
evan@tyvovo.com China 148 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618092446649
sarah@tnjone.com China 1143 58
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
+86-15350851019 +86-15383190639
admin@86-ss.com China 1000 58
Capot Chemical Co.,Ltd.
+86-(0)57185586718 +86-13336195806
sales@capot.com China 29791 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21634 55
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29884 58
Shaanxi Yikanglong Biotechnology Co., Ltd.
17791478691
yklbiotech@163.com CHINA 296 58

セフィキシム  スペクトルデータ(1HNMR、13CNMR、IR1、IR2)


79350-37-1(セフィキシム)キーワード:


  • 79350-37-1
  • YTTERBIUM(III) IONOPHORE I
  • )(carboxymethoxy)imino)acetylamino)-3-ethenyl-8-oxo-,(6r-(6-alpha,7-beta(z)))
  • cl284635
  • fk027
  • fr17027
  • 8-[[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-4-ethenyl-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid
  • (6R,7R)-7-[2-(2-AMINO-4-THIAZOLYL)GLOXYLAMIDO]-8-OXO-3-VINYL-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID, 72-(Z)-[O-(CARBOXYMETHYL)OXIME]TRIHYDRATE
  • CEFIXME TRIHYDRATE
  • CEFIXIME
  • CEFIXIME CEPHALOSPORINS
  • Cefixime (comp)
  • (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
  • Cefixoral
  • Cephoral
  • Unixime
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)- (9CI)
  • Oroken
  • Ceftmral
  • CFIX
  • Saprax
  • Supracef
  • CEFIXIME(7-[[(2-AMINO-4-THIAZOLGL)(CARBOXYMETHOXG)IMINO]ACETYL]AMINO-3-VINYL-8-OXO-5-THIA-1-AZABICYCLO[4,2,0]OCT-2-ENE-2-CARBOXYLICACIDTRIHYDRATE)
  • (6R,6β)-7α-[[(2-Amino-4-thiazolyl)[(Z)-(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[[(Z)-(2-Amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Antibiotic FK-027
  • Cefixime (500 mg)
  • Cexime (500 mg)
  • [6R-[6α,7β(Z)]]-7-[[(2-Amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[(2E)-2-(2-aMino-1,3-thiazol-4-yl)-2-[(carboxyMethoxy)iMino]acetaMido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-({(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-[(CARBOXYMETHOXY)IMINO]ACETYL}AMINO)-8-OXO-3-VINYL-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID
  • (6R,6β)-7α-[[(2-アミノ-4-チアゾリル)[(Z)-(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
  • (6R,7R)-7-[[(2-アミノ-4-チアゾリル)[(Z)-(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
  • セフィーナ
  • セフィキシム
  • セキシム
  • セフスパン
  • 抗生物質FK-027
  • セフパ
  • (6R)-7α-[[(2-アミノ-4-チアゾリル)[(Z)-(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
  • セフィラート
  • (6R,7R)-7-[[(Z)-(2-アミノ-4-チアゾリル)[(カルボキシメトキシ)イミノ]アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
  • セキスパノン
  • セフィキシム (JAN)
  • セファロスポリン類
Copyright 2017 © ChemicalBook. All rights reserved